FDA

The Challenges of Regulating Brain-Machine Interfaces

The Challenges of Regulating Brain-Machine Interfaces

Scholar highlights the fragmented regulatory environment governing advanced neurological technology.

Marketing Formerly Dangerous Drugs

Marketing Formerly Dangerous Drugs

Two scholars find that the removal of FDA health warnings prompts an increase in drug marketing.

The AI Health Care Dilemma

The AI Health Care Dilemma

Scholars explore regulatory approaches to artificial intelligence in the health care sector.

How Factory Farming Could Cause the Next COVID-19

How Factory Farming Could Cause the Next COVID-19

The CDC should recommend agricultural reforms to reduce pandemic risks caused by factory farms.

Toxic Metals in Baby Food Remain Unregulated

Toxic Metals in Baby Food Remain Unregulated

Despite delayed government action, manufacturers can do more to reduce toxic metals in baby food.

Telehealth Abortion Care

Telehealth Abortion Care

Scholars consider how the authorization of telehealth can expand access to medication abortion.

Are Food Regulators Stepping up to the Plate?

Are Food Regulators Stepping up to the Plate?

In this week’s Saturday Seminar, we collect scholarship discussing quality and safety issues within U.S. food regulation.

Using Insurance to Regulate Food Safety

Using Insurance to Regulate Food Safety

Insurance underwriters can help farmers manage the risk of microbial contamination in their fields.

Cancer Moonshot Lands with FDA

Cancer Moonshot Lands with FDA

FDA releases new guidelines for cancer clinical trials in response to President Biden’s anti-cancer initiative.

With Proposed Menthol Cigarette Rule, FDA Says Cool It

With Proposed Menthol Cigarette Rule, FDA Says Cool It

FDA issues proposed rule that would ban menthol as a flavor additive in cigarettes.

Making Regulations on Influencer Advertising Click

Making Regulations on Influencer Advertising Click

Scholars offer approaches to improve regulation of social media marketing.

Emergency Use or Overuse?

Emergency Use or Overuse?

Experts discuss FDA’s COVID-19 emergency authorizations and how to recalibrate the regulatory mechanism.